376 related articles for article (PubMed ID: 7815458)
21. The human phospholamban gene: structure and expression.
McTiernan CF; Frye CS; Lemster BH; Kinder EA; Ogletree-Hughes ML; Moravec CS; Feldman AM
J Mol Cell Cardiol; 1999 Mar; 31(3):679-92. PubMed ID: 10198197
[TBL] [Abstract][Full Text] [Related]
22. Preservation of the in vivo phosphorylation status of phospholamban in the heart: evidence for a site-specific difference in the dephosphorylation of phospholamban.
Calaghan S; White E; Colyer J
Biochem Biophys Res Commun; 1998 Jul; 248(3):701-5. PubMed ID: 9703990
[TBL] [Abstract][Full Text] [Related]
23. [Molecular mechanism underlying calcium handling in diastolic heart failure].
Zhong M; Zhang Y; Zhang W
Zhonghua Yi Xue Za Zhi; 2001 Jun; 81(11):669-72. PubMed ID: 11798946
[TBL] [Abstract][Full Text] [Related]
24. Nature and site of phospholamban regulation of the Ca2+ pump of sarcoplasmic reticulum.
James P; Inui M; Tada M; Chiesi M; Carafoli E
Nature; 1989 Nov; 342(6245):90-2. PubMed ID: 2530454
[TBL] [Abstract][Full Text] [Related]
25. Post-infarction heart failure in the rat is associated with distinct alterations in cardiac myocyte molecular phenotype.
Yue P; Long CS; Austin R; Chang KC; Simpson PC; Massie BM
J Mol Cell Cardiol; 1998 Aug; 30(8):1615-30. PubMed ID: 9737947
[TBL] [Abstract][Full Text] [Related]
26. Gender differences in the modulation of cardiac gene expression by dietary conjugated linoleic acid isomers.
Tappia PS; Dent MR; Aroutiounova N; Babick AP; Weiler H
Can J Physiol Pharmacol; 2007; 85(3-4):465-75. PubMed ID: 17612656
[TBL] [Abstract][Full Text] [Related]
27. Diabetic alterations in cardiac sarcoplasmic reticulum Ca2+-ATPase and phospholamban protein expression.
Kim HW; Ch YS; Lee HR; Park SY; Kim YH
Life Sci; 2001 Dec; 70(4):367-79. PubMed ID: 11798007
[TBL] [Abstract][Full Text] [Related]
28. Phospholamban-dependent effects of C12E8 on calcium transport and molecular dynamics in cardiac sarcoplasmic reticulum.
Shi Y; Karon BS; Kutchai H; Thomas DD
Biochemistry; 1996 Oct; 35(41):13393-9. PubMed ID: 8873607
[TBL] [Abstract][Full Text] [Related]
29. Elevated levels of endogenous adenosine alter metabolism and enhance reduction in contractile function during low-flow ischemia: associated changes in expression of Ca(2+)-ATPase and phospholamban.
Sommerschild HT; Lunde PK; Deindl E; Jynge P; Ilebekk A; Kirkebøen KA
J Mol Cell Cardiol; 1999 Oct; 31(10):1897-911. PubMed ID: 10525427
[TBL] [Abstract][Full Text] [Related]
30. Sarcoplasmic reticulum membrane and heart development.
Michalak M
Can J Cardiol; 1987; 3(5):251-60. PubMed ID: 2440534
[TBL] [Abstract][Full Text] [Related]
31. Gender influences on sarcoplasmic reticulum Ca2+-handling in failing human myocardium.
Dash R; Frank KF; Carr AN; Moravec CS; Kranias EG
J Mol Cell Cardiol; 2001 Jul; 33(7):1345-53. PubMed ID: 11437540
[TBL] [Abstract][Full Text] [Related]
32. Coordinate regulation of SR Ca(2+)-ATPase and phospholamban expression in developing murine heart.
Harrer JM; Haghighi K; Kim HW; Ferguson DG; Kranias EG
Am J Physiol; 1997 Jan; 272(1 Pt 2):H57-66. PubMed ID: 9038922
[TBL] [Abstract][Full Text] [Related]
33. Effects of simvastatin on cardiac performance and expression of sarcoplasmic reticular calcium regulatory proteins in rat heart.
Zheng X; Hu SJ
Acta Pharmacol Sin; 2005 Jun; 26(6):696-704. PubMed ID: 15916736
[TBL] [Abstract][Full Text] [Related]
34. Regulation of sarcoplasmic reticulum protein phosphorylation by localized cyclic GMP-dependent protein kinase in vascular smooth muscle cells.
Cornwell TL; Pryzwansky KB; Wyatt TA; Lincoln TM
Mol Pharmacol; 1991 Dec; 40(6):923-31. PubMed ID: 1836834
[TBL] [Abstract][Full Text] [Related]
35. Molecular cloning and characterization of a Ca2+ + Mg2+-dependent adenosine triphosphatase from rat cardiac sarcoplasmic reticulum. Regulation of its expression by pressure overload and developmental stage.
Komuro I; Kurabayashi M; Shibazaki Y; Takaku F; Yazaki Y
J Clin Invest; 1989 Apr; 83(4):1102-8. PubMed ID: 2522936
[TBL] [Abstract][Full Text] [Related]
36. Unchanged protein levels of SERCA II and phospholamban but reduced Ca2+ uptake and Ca(2+)-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts.
Schwinger RH; Böhm M; Schmidt U; Karczewski P; Bavendiek U; Flesch M; Krause EG; Erdmann E
Circulation; 1995 Dec; 92(11):3220-8. PubMed ID: 7586307
[TBL] [Abstract][Full Text] [Related]
37. Regulation of the Ca2+ pump ATPase by cAMP-dependent phosphorylation of phospholamban.
Tada M; Kadoma M
Bioessays; 1989 May; 10(5):157-63. PubMed ID: 2545189
[TBL] [Abstract][Full Text] [Related]
38. Thyroid hormone induced changes in cardiac proteins and mRNAs.
Dillmann WH; Rohrer D; Popovich B; Barrieux A
Horm Metab Res Suppl; 1987; 17():26-9. PubMed ID: 2895058
[TBL] [Abstract][Full Text] [Related]
39. Decreased cardiac sarcoplasmic reticulum Ca2+ -ATPase activity contributes to cardiac dysfunction in streptozotocin-induced diabetic rats.
Zhao XY; Hu SJ; Li J; Mou Y; Chen BP; Xia Q
J Physiol Biochem; 2006 Mar; 62(1):1-8. PubMed ID: 16909926
[TBL] [Abstract][Full Text] [Related]
40. Role of phospholamban in regulating cardiac sarcoplasmic reticulum calcium pump.
Ambudkar IS; Shamoo AE
Membr Biochem; 1984; 5(2):119-30. PubMed ID: 6143239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
